Treatment with non‐selective beta‐blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis

BACKGROUND & AIMS: The use of non‐selective beta‐blockers has been associated with lower rates of infection and reduced infection‐associated morbidity in patients with cirrhosis. However, it is unknown if these drugs modify the systemic inflammatory response to circulating bacterial DNA. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Gimenez, Paula, Garcia‐Martinez, Irma, Francés, Rubén, Gonzalez‐Navajas, Jose M., Mauri, Montserrat, Alfayate, Rocío, Almenara, Susana, Miralles, Cayetano, Palazon, Jose M., Carnicer, Fernando, Pascual, Sonia, Such, José, Horga, José F., Zapater, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Cirrhosis and Liver Failure
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282820/
https://www.ncbi.nlm.nih.gov/pubmed/29802788
http://dx.doi.org/10.1111/liv.13890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282820/
https://www.ncbi.nlm.nih.gov/pubmed/29802788
http://dx.doi.org/10.1111/liv.13890

Ejemplares similares